论文部分内容阅读
目前指南推荐的治疗主要着眼于低密度脂蛋白(LDL)胆固醇,其他脂质指标被作为次要的或补充性目标。新近出现的数据提示,与LDL相比,测定非高密度脂蛋白(HDL)胆固醇、载脂蛋白-B或总胆固醇/HDL胆固醇比值对预测心血管风险的价值更高。
The current guidelines recommend treatments that focus on low-density lipoprotein (LDL) cholesterol and other lipid targets as secondary or complementary targets. Recent data suggest that determining the ratio of non-high-density lipoprotein (HDL) cholesterol, apolipoprotein-B or total cholesterol / HDL cholesterol is more valuable for predicting cardiovascular risk than LDL.